1. Background {#sec29152}
=============

Coronary artery disease is a major factor of mortality and morbidity in diabetic patients. Actually, risk of myocardial infarction in diabetics equals that of non-diabetic patients with a history of infarction ([@A7624R1]). One of the known complications of diabetes mellitus (DM) is vascular dysfunction ([@A7624R2]-[@A7624R4]). Inability of the coronary vascular response to cardiac hyperactivity might cause the higher incidence of ischemic heart disease in diabetic subjects ([@A7624R5]). Exercise training (ET) has beneficial effects on diabetes and its complications, such as decrease in systemic vascular resistance, heart rate ([@A7624R6]), and blood pressure, increase in insulin sensitivity and improvement in blood lipid profile ([@A7624R7]). Angiogenesis and change in vascular reactivity was reported in different vascular beds by ET ([@A7624R7]). It was shown that regular ET ameliorates endothelial dysfunction through modification of oxidative stress ([@A7624R8]).

Oxidative stress has a pivotal role in the pathogenesis of vascular complications of DM ([@A7624R9]-[@A7624R11]). Thus, improvement of oxidative stress may ameliorate vascular dysfunction induced by DM. Treatment of diabetic rats by antioxidants such as alpha-lipoic acid ([@A7624R9]) and high-dose allopurinol ([@A7624R10]) reversed endothelial dysfunction induced by streptozotocin (STZ).

The compound of grape seed extract (GSE) has antioxidant properties ([@A7624R12]) with greater potency than vitamin C and E ([@A7624R13]). It was reported that impaired endothelium dependent relaxation of aortic rings induced by STZ was improved by grape seed proanthocyanidin extract ([@A7624R14]). To our knowledge, no study to date has examined effects of GSE on coronary vascular bed response to vasoactive agents. On the other hand, we hypothesized that GSE has potential effects on vascular function to scavenge free radicals and potentiate positive effects of ET.

2. Objectives {#sec29153}
=============

Because coronary artery disease frequently occurs in diabetic states, therefore, the present study was designed to determine effects of GSE with and without exercise on coronary vascular bed responses of diabetic rats to phenylephrine (PE), sodium nitroprusside (SNP) and acetylcholine (Ach).

3. Materials and Methods {#sec29160}
========================

3.1. Animals {#sec29154}
------------

Fifty male Wistar strain rats weighing 200 -- 232 grams from the Animal House of the Physiology Research Center at the Ahvaz Jundishapur University of Medical Sciences, Iran, at the beginning of the study were randomly divided in to five groups of 10 rats each: sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD), and GSE treated trained diabetic (TrExD). Diabetes was induced by an intraperitoneal injection of STZ (60mg/kg body weight) dissolved in 0.3ml of normal saline. Control animals were injected with an equivalent volume of vehicle. Dose of GSE was 200 mg/kg and it was administered orally via gavage, once a day. ET was conducted on a treadmill. Duration of the protocol was 8 weeks. All groups were maintained under the same conditions (temperature-controlled room, 22 °C) with a 12-h dark-light cycle, supplied with food and water ad- libitum. Rats were considered diabetic when blood glucose levels were \> 300 mg/dl five days later ([@A7624R15]). The experimental protocol and procedures were submitted and approved by the Institutional Animal Care and Use Committee of the University based on the guidelines for care and use of laboratory animals published by the US National Institutes of Health (NIH Publication, revised 1996).

3.2. Exercise Training Protocol {#sec29155}
-------------------------------

As shown in [Table 1](#tbl7834){ref-type="table"}, rats conducted ET on a treadmill daily for 8 weeks, 1 day after diabetic verification after gavage of GSE.

###### Exercise Training Protocol for Rats on Treadmill

  Week    Belt Speed (m/min)   Inclination, Angle   Total Time (min)
  ------- -------------------- -------------------- ------------------
  **1**   16                   0                    30
  **2**   16                   5                    30
  **3**   16                   10                   45
  **4**   16                   12                   45
  **5**   16                   12                   60
  **6**   16                   12                   60
  **7**   16                   12                   60
  **8**   16                   12                   60

3.3. Preparation of Grape Seed Extract {#sec29156}
--------------------------------------

Vitis Vinifera was confirmed by the Ghazvin Agricultural Research Center, Ghazvin, Iran. Voucher specimen was available in the herbarium at the Department of Phamacognosy, Faculty of Pharmacy, Joundishapur Medical Sciences University, Ahvaz, Iran. Separation of grape seeds from grapes was done manually, dried at room temperature for 7 days and milled to fine powder. The powders were macerated in 70 % ethanol (25% w/v) for 3 days in shade (25 - 30°C) and were stirred 3 times a day. After filtration of the mixture with cheese cloth, the filtrate was dried at room temperature to remove ethanol. Finally grape seed extract was obtained as a powder ([@A7624R16]).

3.4. Preparation of the Perfused Heart {#sec29157}
--------------------------------------

The animals were anesthetized by sodium pentothal (80 mg/kg, i.p) containing 1000 U/kg heparin. Next, the chest was opened and the heart was rapidly excised and placed into a Petri dish containing ice-cold oxygenated modified Krebs-Henseleit solution (KHS). After washing with ice-cold KHS and arresting, the hearts were cannulated via the ascending aorta and immediately transferred to the Langendorff system. The aorta was retroperfused with a modified KHS of the following composition (mM): NaCl 118.4, KCl 4.7, MgSO~4~ H~2~O 1.2, KH~2~PO~4~ 2H~2~O 1.2, NaHCO~3~ 25, CaCl~2~ 2.5 and glucose 11.1 in distilled water. This solution was maintained at 37 °C, bubbled with 5% CO~2~ and 95% O~2~ and perfused the isolated hearts at a constant rate (4ml/min) via a peristaltic pump (Gilson-France). Maximum time between the excision of the heart and the beginning of perfusion was 2 minutes. After the stabilization period (25-30 min), different doses of PE (0.01 -- 100 µM) were administered to the coronary vascular bed as a bolus injection. The vasoconstriction was recorded as a percentage increase in basal perfusion pressure in response to PE. In the pre-contracted coronary vascular bed with 10 μM PE, concentration-response curves to Ach (endothelium dependent vasodilator, 0.01 -- 100 μM) and SNP (endothelium independent vasodilator, 0.001 -- 0.1μM) were measured. The responses were expressed as percentage of relaxation of the PE-induced pre-contraction.

3.5. Drugs {#sec29158}
----------

Streptozotocin, acetylcholine chloride, phenylephrine hydrochloride, heparin sodium and sodium nitroprusside were obtained from Sigma (St. Louis, Mo). Sodium chloride, potassium chloride, magnesium sulfate, sodium hydrogen carbonate, potassium hydrogen orthophosphate, D-glucose and calcium chloride were obtained from Merck Laboratories and sodium pentothal from Rotex Medica, Germany.

3.6. Statistical Methods {#sec29159}
------------------------

Results were expressed as mean ± standard error (SEM) and comparisons between groups for each protocol were performed using repeated measurement ANOVA followed by LSD multiple comparison test or student t-test as appropriate using the SPSS software, Version 16.0, Chicago, IL, USA. A P-value of \< 0.05 was considered significant.

4. Results {#sec29161}
==========

Basal coronary perfusion pressure and vasoconstriction responses to phenylephrine in the isolated coronary vascular bed: Basal coronary perfusion pressure was not statistically different in all groups (SC: 72.7 ± 2.6, SD: 65.4 ± 2.6, TrD: 72.9 ± 3.8, ExD: 67.4 ± 2.8 and TrExD: 66.1 ± 2 mm Hg respectively) ([Figure 1](#fig6381){ref-type="fig"}). Contractile response to phenylephrine (1 -- 100 μM) increased dose dependently, but did not significantly change in different groups ([Figure 2](#fig6382){ref-type="fig"}).

![Basal coronary perfusion pressure (mean ± SEM, n = 7-8, CPP) of coronary vascular beds isolated from sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD) and GSE treated trained diabetic (TrExD) group. There was no significant difference between groups.](ircmj-15-7624-i001){#fig6381}

![Vasoconstrictor responses (mean ± SEM, n = 8-10) to phenylephrine of coronary vascular beds isolated from sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD) and GSE treated trained diabetic (TrExD) group. There was no significant difference between groups.](ircmj-15-7624-i002){#fig6382}

Vasorelaxation responses to sodium nitroprusside (coronary endothelium-independent relaxation): STZ significantly (P \< 0.01) decreased the relaxation responses to SNP (0.01 -- 1 µM) in the PE (10 μM) pre-contracted coronary vascular bed (i.e. % of maximum relaxation responses in control and diabetic rats were 42.6 ± 3.3 and 28.6 ± 3, respectively). Combined ET and GSE (P \< 0.01) improved the relaxation response to SNP (41.5 ± 3.2) ([Figure 3](#fig6383){ref-type="fig"}). % Maximum coronary independent dilation in SD, TrD, ExD, and TrExD groups was 67.3, 80.7, 74.1, and 97.5 respective of the control group ([Figure 4](#fig6384){ref-type="fig"}).

![Vasodilator responses to sodium nitroprusside (Mean ± SEM, n = 7-8) in the phenylephrine (10 μM) pre-contracted coronary vascular beds isolated from sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD) and GSE treated trained diabetic (TrExD) groups. \* P \< 0.05, \*\* P \< 0.01 indicates a significant difference from the sedentary diabetic group (tow way ANOVA followed by LSD).](ircmj-15-7624-i003){#fig6383}

![Ratio between maximum relaxation of different groups and control groups. Sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD) and GSE treated trained diabetic (TrExD) groups. \* P \< 0.05, \*\* P \< 0.01 and \*\*\* P \< 0.001 indicate a significant difference from the sedentary diabetic group and ‡ P \< 0.05 and ‡‡ P \< 0.01 demonstrate a significant difference from the control group (tow way ANOVA followed by LSD).](ircmj-15-7624-i004){#fig6384}

Vasorelaxation responses to acetylcholine (Coronary endothelium-dependent relaxation); as shown in [Figure 5](#fig6385){ref-type="fig"}, maximum coronary response to Ach in the control and diabetic groups pre-contracted with PE (10 µM) reached 26.46 ± 2.15 and 8.14 ± 1.27, respectively. This significant difference (P \< 0.001) between SC and SD groups was partially (P \< 0.05) improved by GSE (15.63 ± 2.3) or ET (17.03 ± 2.93) and perfectly (P \< 0.001) restored by combined ET and GSE (23.76 ± 4.24). Percentage of Maximum coronary independent dilation in SD, TrD, ExD, and TrExD groups was 30.6, 64.4, 57.1, and 89.8, respective of that of the control group ([Figure 4](#fig6384){ref-type="fig"}).

![Vasodilator responses to acetylcholine (mean ± SEM, n = 7-8) in the phenylephrine (10 μM) pre-contracted coronary vascular beds isolated from sedentary control (SC), sedentary diabetic (SD), trained diabetic (TrD), GSE treated sedentary diabetic (ExD) and GSE treated trained diabetic (TrExD) groups.](ircmj-15-7624-i005){#fig6385}

5. Discussion {#sec29162}
=============

Our data showed STZ-induced diabetes and vasoconstriction response to PE of coronary vascular bed and that GSE with and without ET did not significantly change basal perfusion pressure. Endothelial independent relaxation to SNP and endothelial dependent relaxation to Ach was significantly reduced by STZ. Eight weeks of ET or GSE partially improved responses to Ach, but did not improve responses to SNP. Combined ET and GSE perfectly restored endothelial dependent and independent dysfunction induced by STZ.

Impairment of vascular function may contribute to the pathogenesis of vascular complications induced by diabetes ([@A7624R11], [@A7624R17], [@A7624R18]). Some mechanisms of these impairments in diabetes may include factors that decrease endothelium derived relaxation factors such as reduced conversion of arginine to NO ([@A7624R19]), increase in nitric oxide synthase (NOS) inhibitor ([@A7624R20]), reduced NOS cofactor tetrahydrobiopterin bioavailability ([@A7624R21]), and increase in endothelium derived relaxing factor (EDRF) destruction by oxidative stress ([@A7624R22]), increase in endothelium-derived constricting factors ([@A7624R23], [@A7624R24]), endothelial cell apoptosis ([@A7624R25]), and impairment of smooth muscle cell function ([@A7624R26]).

In our study, DM impaired endothelium independent relaxation that is in accordance with other reports ([@A7624R27]-[@A7624R29]). Since relaxation to SNP (NO donor) was shown to be impaired, it is possible that vascular smooth muscle did not respond to NO. Reduction of endothelium dependent relaxation is well known and occurs in type 1 ([@A7624R12], [@A7624R30], [@A7624R31]) and type 2 ([@A7624R32]) diabetes. Relaxation induced by endothelium, reflects the function of both endothelial cells and smooth muscle cells. In our study, STZ-induced reduction of endothelial function was 69.4% whereas endothelium independent relaxation was only 32.7%. Therefore, endothelial impairment was 69.4% minus 32.7% equal to 36.7%.

In accordance to other reports ([@A7624R33], [@A7624R34]), ET partially improves endothelial dysfunction. The beneficial effects of ET might become available through improvement of hyperglycemia (our unpublished data) and insulin resistance that prevents impairment of endothelium dependent hyperpolarizing factor (EDHF) and EDRF, amelioration of diabetic-induced oxidative stress and by reduction of leukocyte adhesion (8), significant reduction in glycosylated hemoglobin (HbA1c), improvement of blood lipid levels, and decrement of blood pressure ([@A7624R7]), improvement of arterial compliance ([@A7624R35]), induction of angiogenesis and vasculature reactivity ([@A7624R36], [@A7624R37]), increment of NO production (37), increment of eNOS protein ([@A7624R38], [@A7624R39]), and increment of eNOS dimerization that increases coupling of the enzyme to facilitate production of NO ([@A7624R7]).

It was shown that DM is associated with overproduction of oxidative stress ([@A7624R40]-[@A7624R42]). Oxidative stress may affect endothelial function through reduction of NO bioavailability or by serving as a contracting factor derived from endothelium ([@A7624R43]) or by reduction of EDHF ([@A7624R44]). EDHF hyperpolarizes the underlying smooth muscle via activation of K+ channels ([@A7624R45]) or via gap junction ([@A7624R10]) and thus relaxes the smooth muscles. It was reported that reactive oxygen species may induce gap junction dysfunction in diabetes ([@A7624R46]).

GSE could improve diabetes-induced endothelial dysfunction. Vasorelaxation of GSE may be done via NO by phosphorylation of eNOS ([@A7624R47]) and blockage of potential-dependent calcium channels and inhibition of calcium release ([@A7624R48]). On the other hand, GSE is known as a powerful antioxidant ([@A7624R13]). It was shown that antioxidants such as α-lipoic acid ([@A7624R9]), Quercetin ([@A7624R49]), xanthine oxidase inhibitor and allopurinol ([@A7624R10]) have beneficial effects on both NO and EDHF mediated endothelium-dependent relaxation of diabetic states. Positive effects of vitamin E plus insulin in improving parameters of cardiac function and reduction of oxidative stress and apoptosis has been reported ([@A7624R50]). Superoxide dismutase and tocopherol-acetate reduced perivascular fibrosis and significantly changed the contractile system in myocardium ([@A7624R51]).

To our knowledge, this study is the first report showing the chronic beneficial effects of combined ET and GSE on coronary vascular function in diabetes. Complete improvement of endothelial function shows that this combination is more effective than ET or GSE alone. Since this study was not designed to find exact mechanisms of this positive combination, further experiments must be done to answer this question. Although the exact mechanisms of these actions are not clear, however the combination of the mechanisms mentioned above and other mechanisms may be considered.

Basal coronary perfusion pressure was not changed by diabetes, ET and GSE with and without ET. Since basal coronary perfusion pressure is affected by both nitric oxide (NO) and Prostaglandins ([@A7624R52]), these mediators (NO and prostaglandins) are not affected by STZ or other interventions.

In our study, diabetes, ET, GSE and combined ET and GSE did not change the coronary vascular bed response to PE, which is in agreement with others ([@A7624R17], [@A7624R53]), although a reduction ([@A7624R10], [@A7624R54]) and increment ([@A7624R55]) in this response have also been reported. Some factors that describe these discrepancies are attributed to the duration of diabetes and to the animal species and vascular bed studied ([@A7624R54]).

In conclusion, the data indicated that ET combined with GSE administration had more significant effects than ET or GSE alone, may constitute convenient and inexpensive therapeutic approach to diabetic vascular complications.
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**Implication for health policy makers/practice/research/medical education:**Our data showed that grape seed extract and exercise training combination had more significant improving effects on endothelial dysfunction than exercise training or grape seed extract alone, indicating that administration of an antioxidant with exercise increases their beneficial effects; so that exercise training combined with grape seed extract restores vasodilatory response to acetylcholine and sodium nitroprusside more significantly than exercise training or grape seed extract alone and may constitute a convenient and inexpensive therapeutic approach to diabetic vascular complications.
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